Natco Pharma on Tuesday announced the launch of generic Pomalidomide capsules indicated for treatment of adult patients with blood and bone marrow cancer in the US market in partnership with ...

Feb 25 – Zydus Lifesciences will launch generic versions of semaglutide injections for obesity and diabetes ‌in India after patent expiry of the Ozempic active ingredient in late March, it said on ...